Skip to content

Initial admission to a general ward after emergency thrombolysis for acute ischemic stroke

A retrospective study comparing the cost-effectiveness, efficacy, and safety of initial admission to a general ward versus an intensive care unit after intravenous thrombolysis in the emergency room for patients with acute ischemic stroke

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126389
Enrollment
Unknown
Registered
2026-06-08
Start date
2026-06-08
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke treated with intravenous thrombolysis in the emergency department within 24 hours of symptom onset

Interventions

General ward group:NA
NICU/ICU group:NA

Sponsors

The First Affiliated Hospital of University of South China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years; 2. Onset within 24 hours; 3. Acute ischemic stroke; 4. Received intravenous thrombolysis in the emergency department and was hospitalized.

Exclusion criteria

Exclusion criteria: 1. Bridging thrombectomy; 2. In-hospital stroke; 3. Conditions unsuitable for management in a general ward, such as impaired consciousness, unstable vital signs, or endotracheal intubation; 4. Failure to complete the planned 90-day follow-up; 5. Current participation in another clinical trial.

Design outcomes

Primary

MeasureTime frame
Incremental Cost-Effectiveness Ratio (ICER);

Secondary

MeasureTime frame
Out-of-pocket inpatient costs;Length of stay;Proportion with NIHSS score reduction >=2 points;Proportion with NIHSS score reduction >=4 points;Proportion of patients with 90-day mRS score 0–3;Death at discharge proportion;Proportion of patients with 90-day mRS score 0–2;Proportion of symptomatic intracranial hemorrhage;Proportion of patients with 90-day mRS score 0–1;90-day mortality rate;Proportion of patients with any intracranial hemorrhage;90-day mRS distribution;

Countries

China

Contacts

Public ContactRuan Zhongfan

The First Affiliated Hospital of University of South China

ruanzhongfan@sina.com+86 734 857 8728

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026